Clinical Trial Update: Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring tremelimumab in combination with intravesical Bacillus Calmette-Guérin for high-risk non-muscle-invasive bladder cancer af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: Changhai Hospital | Conditions: Bladder Cancer | Phase 2 | Status: RECRUITING